Product Information
TOBRAMYCIN 300 MG/5 ML AMPULE is a generic product labeled by Micro Labs Limited, priced at $1.0840 per ML under NDC 42571040892. Its NADAC has been published 99 times since Nov 13, 2024.
FDA first approved this application on Jul 27, 2023. Its Orange Book therapeutic-equivalence code is AN.
Strength
300 mg/5mL
Manufacturer
Micro Labs LimitedNDC
42571040892
Classification
Generic
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA217344FDA Approved
7/27/2023
TE Code
AN
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has been published 99 times since Nov 13, 2024, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0840 per ML |
|---|---|
| All-time high | $1.7603 (Jul 16, 2025) |
| All-time low | $1.0672 (Mar 18, 2026) |
| 52-week high | $1.4721 |
| 52-week low | $1.0672 |
| Median price | $1.2618 |
| Average price | $1.3207 |
| Largest weekly change | -33.9% (Nov 20, 2024) |
| Weeks tracked | 99 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tobramycin solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tobramycin solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 300 MG/5 ML AMPULE?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 300 MG/5 ML AMPULE, manufactured by Micro Labs Limited, is $1.0840 per ML (NDC 42571040892), effective Sep 30, 2026.
How has the price of TOBRAMYCIN 300 MG/5 ML AMPULE changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has declined 36.6%. It has been tracked across 99 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 300 MG/5 ML AMPULE?
Since Nov 13, 2024, the NADAC for TOBRAMYCIN 300 MG/5 ML AMPULE has ranged from a low of $1.0672 (Mar 18, 2026) to a high of $1.7603 (Jul 16, 2025), with a median of $1.2618 per ML.
Are there cheaper alternatives to TOBRAMYCIN 300 MG/5 ML AMPULE?
No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 300 MG/5 ML AMPULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOBRAMYCIN 300 MG/5 ML AMPULE?
TOBRAMYCIN 300 MG/5 ML AMPULE (NDC 42571040892) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.